NL-OMON26643招募中不适用
Resistant HYpertension: MEasure to Reach Targets
Erasmus Medical Centre0 个研究点目标入组 310 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 310
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Resistant hypertension: office blood pressure > 140/90 mmHg and 24h ABPM (ambulatory blood pressure measurement) daytime blood pressure > 135/85 mmHg despite a medication regimen of antihypertensive drugs from at least three classes including a diuretic.
- •- Use of at least two drugs for which DBS-analysis is available (enalapril, perindopril, losartan, valsartan, hydrochlorothiazide, spironolactone, amlodipine and nifedipine.
排除标准
- •- Not providing informed consent or not capable of giving informed consent
- •- Kidney transplantation
研究者
相似试验
招募中
不适用
Resistant HYpertension: MEasure to ReaCh Targetshigh blood pressure10057166HypertensionNL-OMON50303Erasmus MC, Universitair Medisch Centrum Rotterdam392
招募中
不适用
A Study to achieving target blood pressure goal in hypertension through Home Blood Pressure Monitoring during initial combination therapyCTRI/2022/08/045116Dr Nagaraj Desai
进行中（未招募）
1 期
Optimal Treatment of Drug Resistant Hypertension - Optimal Treatment of Drug Resistant HypertensioMedDRA version: 15.0 Level: PT Classification code 10020772 Term: Hypertension System Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2008-007149-30-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge346
已完成
4 期
The effect of aggressive antihypertensive therapy in hypertensive patients with left ventricular diastolic dysfunctioHypertensionJPRN-UMIN000002487Kawasaki Medical School60
已完成
4 期
Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)JPRN-C000000137HOMED-BP Study Group9,000